Leukemia drug TGRX-678 gets a body scan: tiny study tracks its journey
Knowledge-focused
Completed
This completed Phase 1 study gave 6 healthy Chinese men a single dose of the leukemia drug TGRX-678 to see how the body absorbs, breaks down, and gets rid of it. Researchers measured radioactivity in blood, urine, and stool to map the drug's path. No treatment was given—just unde…
Phase: PHASE1 • Sponsor: Shenzhen TargetRx Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:41 UTC